Searchable abstracts of presentations at key conferences in endocrinology

ea0035p114 | Calcium and Vitamin D metabolism | ECE2014

A novel mutation in GATA3 gene in HDR syndrome

Kim Doo-Man , Yang Seung , Park Juri , Son Ho Young

The combination of hypoparathyroidism, sensorineural deafness and renal dysplasia, named HDR syndrome, is a rare disease. Heterozygous abnormalities of GATA3 gene are associated with this syndrome. Here we report a novel heterozygous mutation, c.255_256ins4 (GTGC), in GATA3 gene. A 41-year-old man was diagnosed as having idiopathic hypoparathyroidism and has been treated with 1α-hydroxyvitamin D3 and calcium carbonate. Three years later, he had a hearing...

ea0070aep1069 | Hot topics (including COVID-19) | ECE2020

The role of growth hormone device optimisation in patient-reported outcomes: Real-world evidence from South Korea

Lee Ji-Eun , Lee Kee-Hyoung , Park Mi Jung , Yang Seung , Young Kim Eun , Rhie Young-Jun , Jung Min-Ho , Yang Aram , Kim Shin-Hye , Yoojin Chung Lindsey , Young Ko Su , Ju Lee Young , Nedjatian Navid , Yeong Chung Woo

Growth hormone (GH) therapy (GHT) requires long-term commitment to daily sc GH injections that may present adherence challenges. Patient preference and adherence have been shown to be affected by delivery devices in association with convenience of administration, level of injection-site pain, confidence in correct dose administration and satisfaction with the device. This survey investigated if switching GH device – from NordiLet/others to NordiFlex – improved pati...